BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review

Bulletin Express

2025/10/22

BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).

Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1165894783"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165894783\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165894783?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165894783","market":"hk","top_or_hot":-1,"title":"BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-22 18:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1165894783","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165894783","pubTimestamp":1761130063,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines Ltd.(06160)公布2025年第三季度财务业绩发布日期和审计委员会审查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).\nFollowing the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}